http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113209113-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-634 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-634 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032 |
| filingDate | 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113209113-B |
| titleOfInvention | Application of forsythoside A in preparation of anti-esophageal squamous carcinoma medicament |
| abstract | The invention provides application of forsythoside A in preparation of an anti-esophageal cancer medicament, wherein the forsythoside A is used as an active ingredient in the anti-esophageal squamous cancer medicament and has a molecular formula of C 29 H 36 O 15 . Forsythoside A is mainly used for inhibiting the proliferation, clone formation and cell migration of esophageal squamous carcinoma cells, or blocking the cell cycle of esophageal squamous carcinoma cells and promoting the apoptosis of esophageal squamous carcinoma cells so as to achieve the purpose of resisting esophageal squamous carcinoma; therefore, forsythoside A has inhibitory effect on malignant phenotype of esophageal squamous carcinoma. |
| priorityDate | 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.